Search alternatives:
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
based case » base case (Expand Search), based cancer (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
based case » base case (Expand Search), based cancer (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
21
-
22
Colon tissue and organoid AJC protein expression is decreased with LD shifting in Per2::Luc mice.
Published 2021“…Both demonstrated a significant decrease in E-cadherin in the shifted mice (p<0.05). …”
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
HFD decreases ITM and alters metabolic homeostasis.
Published 2025“…Two-way ANOVA, n.s., not significant, ** p < 0.01). <b>(F)</b> Long-term memory (LTM) was significantly decreased in the HFD group. …”
-
35
-
36
B2 decreases glycolytic intermediates in cells.
Published 2025“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
-
37
-
38
Depletion of ERp29 decreases cellular Proinsulin.
Published 2020“…(D, E) Transiently transfected Min-6 cells were lysed and analyzed by ELISA. Proinsulin levels decreased when transfected with ERp29-targeting siRNA as compared to controls (D, p = 0.0309), but Insulin content did not significantly change (E, p = ns).…”
-
39
Regenerating axons are increased by ATRA and decreased by clodronate.
Published 2021“…Compared to PBS-treated, the number of regenerating axons is doubled by ATRA treatment, decreased by 30% by clodronate, and, in the case of ATRA combined with clodronate, is not significantly different.…”
-
40
Base-case analysis.
Published 2025“…When the CET was relaxed to 0.90 times GDP per capita (US$11,284.476), the probability of cost-effectiveness for AOM after a 40% price reduction rose to 85.10%. Scenario analyses conducted over a time horizon extending from 10 to 30 years showed that the ICER decreased significantly with longer follow-up, gradually approaching the 0.51GDP threshold and remaining below the 0.90 GDP threshold throughout the analysis.…”